Commentary on ‘Lentivirus‐mediated gene therapy for Fabry disease: 5‐year end‐of‐study results from the Canadian FACTS trial’
Saved in:
| Main Authors: | Alessandro Rossi, Nicola Brunetti‐Pierri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Clinical and Translational Discovery |
| Online Access: | https://doi.org/10.1002/ctd2.70038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lentivirus‐mediated gene therapy for Fabry disease: 5‐year End‐of‐Study results from the Canadian FACTs trial
by: Aneal Khan, et al.
Published: (2025-01-01) -
O36: Lentiviral gene therapy for Fabry disease in the Canadian FACTS trial: 5 year end of study results
by: Aneal Khan, et al.
Published: (2025-01-01) -
Towards a one‐time cure for Fabry disease: Lentivirus‐mediated haematopoietic stem and progenitor cell gene therapy
by: Rina Kansal
Published: (2025-04-01) -
Direct Amplification and Cloning of Up to 5-kb Lentivirus Genomes from Serum
by: Lennart Holterman, et al.
Published: (1996-08-01) -
The base excision repair pathway is required for efficient lentivirus integration.
by: Kristine E Yoder, et al.
Published: (2011-03-01)